Wellbeing Digital Sciences Inc. Stock price

Equities

MEDI

CA94946J1084

Healthcare Facilities & Services

End-of-day quote NEO Exchange 06:00:00 2023-04-03 pm EDT 5-day change 1st Jan Change
0.015 CAD +200.00% Intraday chart for Wellbeing Digital Sciences Inc. -.--% -.--%
Sales 2020 - Sales 2021 1.13 1.53 Capitalization 1.8M 2.44M
Net income 2020 1M 1.35M Net income 2021 -31M -41.97M EV / Sales 2020 * -
Net cash position 2020 * - 0 Net cash position 2021 * - 0 EV / Sales 2021 * -
P/E ratio 2020 *
-
P/E ratio 2021 *
-
Employees -
Yield 2020 *
-
Yield 2021 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Cardinal Group Companies LLC entered into an agreement to acquire KGK Science Inc. from Wellbeing Digital Sciences Inc. for $2 million. CI
Wellbeing Digital Sciences Inc.'s Wholly Owned Subsidiary KGK Sciences Inc Begins Recruitment in First-Of-Its-Kind Health Canada Approved Psilocybin Trial CI
KGK Science Inc. Awards an Institution Wide Cannabis Research License for Their New Facility by Health Canada CI
Wellbeing Digital Sciences Inc. Appoints Mohammad Sharifi to Board of Directors CI
Wellbeing Digital Sciences Inc. Announces Management Changes CI
Nova Mentis Enters into Research Services Contract with KGK Science for Phase II A Clinical Trial CI
Wellbeing Digital Signs LOI Manage Additional Clinics CI
Wellbeing Digital Sciences Inc. Reports Earnings Results for the Full Year Ended July 31, 2022 CI
Wellbeing Digital Sciences Inc. Reports Earnings Results for the Fourth Quarter Ended July 31, 2022 CI
Wellbeing Digital Sciences Inc. Appoints Najla Guthrie to the Benzinga Psychedelic Advisory Council CI
Wellbeing Digital Seeks Acquisitions CI
Wellbeing Digital Sciences Inc. Announces Change of Financial Year End from July 31 to October 31 CI
Wellbeing Digital Sciences Appoints Natalie Dolphin as VP of Marketing and Investment Relations CI
Wellbeing subsidiary KGK Science Announces Positive Clinical Trial Results of GJ 191 (JointAlive(R)) Supplementation in Treating OA CI
Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial Officer CI
More news
1 year
0.01
Extreme 0.005
0.02
3 years
0.01
Extreme 0.005
0.58
5 years
0.01
Extreme 0.005
0.58
10 years
0.01
Extreme 0.005
0.58
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-05-31
Director of Finance/CFO 49 22-06-14
Chief Tech/Sci/R&D Officer - 21-05-31
Members of the board TitleAgeSince
Director/Board Member 37 21-01-06
Chief Executive Officer - 21-05-31
Director/Board Member 42 20-09-17
More insiders
Wellbeing Digital Sciences Inc. is a Canada-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is also supported by a network of North American clinics that provide therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services with a focus on nutraceutical and emerging health care products.
More about the company
  1. Stock
  2. Equities
  3. Stock Wellbeing Digital Sciences Inc. - NEO Exchange